Hubei Guangji Pharmaceutical's subsidiary received the re-registration approval notice for vitamin B6 chemical raw materials.

Hubei Guangji Pharmaceutical (000952.SZ) announced that its controlling subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd. (referred to as "Huisheng Company"), recently received the "Chemical Raw Material Drug Re-registration Approval Notification" issued by the Hubei Provincial Food and Drug Administration. Vitamin B6: The raw material drug is used for the production of vitamin B6 tablets and vitamin B6 injections. The acquisition of the above-mentioned "Chemical Raw Material Drug Re-registration Approval Notification" ensures the stability and continuity of the production and sales qualifications of vitamin B6.